D. Sagebiel (Berlin, Germany), R. Zaleskis (Copenhagen, Denmark)
M. tuberculosis W-strain: MDR or no?
I. A. Vassilieva, L. N. Tchernoousova (Moscow, Russia)
|  |
TB and drug-resistant TB report from a referral TB unit of Athens. The impact of immigration during the years 1995–2000
A. A. Papavassiliou, V. K. Tamvakis, V. G. Sgountzos, M. G. Toumbis (Athens, Greece)
|  |
Tuberculosis resistance patterns at a prison in Lima, Peru
J. Agapito, E. Santiago, J. Leey, J. Best, R. Accinelli (Lima, Peru)
| |
Early diagnosis of sub-clinical multidrug-resistant tuberculosis
L. Richeldi, M. Losi, K. Ewer, D. M. Hansell, P. Roversi, L. M. Fabbri, A. Lalvani (Modena, Italy; Oxford, London, United Kingdom)
| |
DOTS program is associated with a reduction of multidrog resistant tuberculosis prevalence in new cases
S. A. Antoniu, T. T. Mihaescu (Iasi, Romania)
| |
Second and third line anti-tuberculosis drug's side effects during the treatment of patients with multidrug resistant tuberculosis (MDR TB)
E. Livchane (Moscow, Russia)
| |
New era of artificial pneumothorax in the management of multidrug resistant (MDR) pulmonary tuberculosis
V. Y. Mishin, I. A. Vassilieva (Moscow, Russia)
| |
The surgery of multidrug resistant tuberculosis
M. M. Herrag, T. T. Salma, A. A. A. Said, E. E. F. E. Mt (Rabat, Morocco)
| |